J. Fikes

发表

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery.

A. Sette, J. Fikes, 2003, Current opinion in immunology.

Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

A. Sette, F. Chisari, R. Chesnut, 1999, Journal of immunology.

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

John Sidney, Alessandro Sette, Scott Southwood, 2001, The Journal of experimental medicine.

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.

J Alexander, A Sette, J Sidney, 2002, Tissue antigens.

Improved Immunogenicity of an Immunodominant Epitope of the Her-2/neu Protooncogene by Alterations of MHC Contact Residues1

J. Sidney, A. Sette, R. Kiessling, 2004, The Journal of Immunology.

Encoding Multiple HLA-Restricted CTL for Development of Minigene DNA Vaccines Utilization of MHC Class I Transgenic Mice

A. Sette, R. Chesnut, G. Hermanson, 1999 .

Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity.

A. Sette, F. Chisari, E. Appella, 1998, Human immunology.

Novel secA alleles improve export of maltose-binding protein synthesized with a defective signal peptide

J. Fikes, P. Bassford, John D. FIKESt, 1989, Journal of bacteriology.

Epitope identification and vaccine design for cancer immunotherapy.

J. Sidney, A. Sette, R. Chesnut, 2002, Current opinion in investigational drugs.

Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs

H. Fujii, S. Southwood, J. Fikes, 2006, Cancer Immunology, Immunotherapy.

Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles.

J. Sidney, A. Sette, E. Celis, 1994, Molecular immunology.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

H. Grey, A. Sette, R. Chesnut, 1998, Vaccine.

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

H. Grey, A. Sette, F. Chisari, 1995, Molecular immunology.

The Rational Design of T-Cell Epitopes With Enhanced Immunogenicity

J. Fikes, 2004 .

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

T. Gooley, K. Knutson, K. Schiffman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

Y. Horiguchi, M. Murai, M. Tachibana, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Linear PADRE T Helper Epitope and Carbohydrate B Cell Epitope Conjugates Induce Specific High Titer IgG Antibody Responses1

A. Sette, R. Chesnut, D. Bundle, 2000, The Journal of Immunology.

This information is current as Responses Induce Specific High Titer IgG Antibody Carbohydrate B Cell Epitope Conjugates Linear PADRE T Helper Epitope and

A. Sette, R. Chesnut, J. Paulson, 2000 .

Large-T-antigen-p53 complex formation is not cold sensitive in a cold-sensitive transformant induced by simian virus 40 mutant tsA1499

N. Bouck, J. Fikes, M. Rundell, 1984, Journal of virology.

Formulation and characterization of a ten-peptide single-vial vaccine EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy

J. Fikes, M. Newman, G. Ishioka, 2008, Human vaccines.

Screening of HLA-A 24-restricted Epitope Peptides from Prostate-specific Membrane Antigen That Induce Specific Antitumor Cytotoxic T Lymphocytes 1

Y. Horiguchi, M. Murai, M. Tachibana, 2002 .

A pilot study of the CY‐1899 T‐cell vaccine in subjects chronically infected with hepatitis B virus

A. Sette, G. Minuk, T. Wright, 1999, Hepatology.

The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.

H. Grey, A. Sette, F. Chisari, 1997, Journal of immunology.

Contact Residues Protooncogene by Alterations of MHC Immunodominant Epitope of the Her-2/neu Improved Immunogenicity of an

J. Sidney, A. Sette, R. Kiessling, 2004 .

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function.

A. Sette, R. Chesnut, P. Streeter, 2001, Vaccine.

Striking conservation of TFIID in Schizosaccharomyces pombe and Saccharomyces cerevisiae

F. Winston, L. Guarente, J. Fikes, 1990, Nature.

A cDNA encoding a human CCAAT-binding protein cloned by functional complementation in yeast.

L. Guarente, J. Fikes, D. Becker, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation.

A Sette, J Sidney, J. Sidney, 2001, Biologicals : journal of the International Association of Biological Standardization.

The optimization of helper T lymphocyte (HTL) function in vaccine development

Alessandro Sette, Brian Livingston, Ettore Appella, 1998, Immunologic research.

Factors influencing the in vitro translocation of the Escherichia coli maltose-binding protein.

J. Fikes, D. N. Collier, P. Bassford, 1989, The Journal of biological chemistry.

Analysis of mutational alterations in the hydrophilic segment of the maltose-binding protein signal peptide

J. Fikes, P. Bassford, J. Puziss, 1989, Journal of bacteriology.

Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.

J. Sidney, A. Sette, R. Chesnut, 1999, Human immunology.

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

C Crimi, R W Chesnut, A Sette, 1996, International immunology.

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

J. Berzofsky, C. Rice, A. Sette, 1995, Journal of virology.

The Schizosaccharomyces pombe homolog of Saccharomyces cerevisiae HAP2 reveals selective and stringent conservation of the small essential core protein domain

L. Guarente, J. Fikes, L Guarente, 1991, Molecular and cellular biology.

Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A∗0201-Binding Affinity1

Alessandro Sette, Scott Southwood, A. Sette, 2001, The Journal of Immunology.

Affinity 0201-Binding * Correlates with HLA-A Recognition of Naturally Processed Epitopes Different Tumor-Associated Antigens: Identification of New Epitopes from Four

A. Sette, R. Chesnut, E. Celis, 2001 .

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

G Y Ishioka, J Fikes, G Hermanson, 1999, Journal of immunology.

Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif

John Sidney, Alessandro Sette, Brian Livingston, 2001, Journal of Virology.

Mutations in yeast HAP2/HAP3 define a hybrid CCAAT box binding domain.

Y. Xing, L. Guarente, J. Fikes, 1993, The EMBO journal.

Studies on the mode of action of a bacteriocin produced by Bacillus stearothermophilus.

B. Crabtree, J. Fikes, B. D. Barridge, 1983, Canadian journal of microbiology.

Design of multi-epitope, analogue-based cancer vaccines

A. Sette, J. Fikes, 2003, Expert opinion on biological therapy.

A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-γ and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery1

A. Sette, E. Appella, R. Chesnut, 2002, The Journal of Immunology.

Therapeutic Vaccination in Humans Infection and its Role in Response to Associated with Chronic Hepatitis B Virus Altered Helper T Lymphocyte Function

A. Sette, F. Chisari, R. Chesnut, 1999 .

A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu88-102

Soldano Ferrone, James N Ingle, L. Hartmann, 2010, Clinical Cancer Research.

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

L. Hartmann, P. Wettstein, K. Knutson, 2008, Cancer research.

Active transport of maltose in membrane vesicles obtained from Escherichia coli cells producing tethered maltose-binding protein

H. Nikaido, K. Gehring, D. Dean, 1989, Journal of bacteriology.

Export of unprocessed precursor maltose-binding protein to the periplasm of Escherichia coli cells

J. Fikes, J D Fikes, P J Bassford, 1987, Journal of bacteriology.

Mutational alterations affecting the export competence of a truncated but fully functional maltose-binding protein signal peptide

V. Bankaitis, J. Fikes, P. Bassford, 1987, Journal of bacteriology.

Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site.

J. Fikes, G. A. Barkocy-Gallagher, J D Fikes, 1990, The Journal of biological chemistry.

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

L. Hartmann, A. Nassar, J. Ingle, 2009, Cancer Immunology, Immunotherapy.

HLA expression in cancer: implications for T cell-based immunotherapy

Alessandro Sette, A. Sette, R. Chesnut, 2001, Immunogenetics.

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

J. Sidney, A. Sette, S. Southwood, 2001, The Journal of experimental medicine.